Escape of mesenteric vessels from adrenergic and nonadrenergic vasoconstriction.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure; D002415:Cats; D004558:Electric Stimulation; D008638:Mesenteric Arteries / Q000187:drug effects* / Q000294:innervation; D008680:Metaraminol / Q000494:pharmacology; D008729:Methoxamine / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology*; D014655:Vascular Resistance; D014662:Vasoconstrictor Agents / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology; D014666:Vasomotor System / Q000187:drug effects; D014667:Vasopressins / Q000494:pharmacology
D000318:Adrenergic beta-Agonists; D011453:Prostaglandins; D013566:Sympathomimetics; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D014667:Vasopressins; D000804:Angiotensin II; D010656:Phenylephrine; D008680:Metaraminol; D011433:Propranolol; D008729:Methoxamine; D009638:Norepinephrine